Medibio: Raises $3.5M via placement and SPP

  • Health technology company Medibio (MEB) plans to raise up to $3.5 million through a capital raise and share purchase plan
  • The company has received commitments for a $3 million placement of around 333.3 million new fully paid ordinary shares
  • Medibio will offer investors one free attaching option for every four new shares issued at 1.5 cents per option
  • Medibio will also conduct a $500,000 share purchase plan, which expected to fully underwritten
  • Proceeds will fund a depressive burden trial, MEBsleep and ilumen product commercialisation activities and consumer app development
  • Medibio is up 11.11 per cent and trading at 1 cent per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Visa Strengthens Ties as Anchor Investor in PayPay IPO

Visa commits to supporting PayPay's growth through IPO investment. Highlights: Visa invests as anchor in PayPay's IPO.This move highlights...

Santander and Mastercard Complete Europe’s First Live Agentic AI Transaction

This groundbreaking transaction marks a milestone in AI-driven financial technology. Highlights: Santander and Mastercard execute Europe’s first agentic AI...

Apple Strengthens Reach with Apple Pay Launch in India

Apple Pay expands its footprint, aiming to capture the Indian digital payments market. Highlights: Apple Pay officially launches in...

Brink’s Strengthens Position with $6.6B NCR Acquisition

Brink's expands its services through strategic acquisition of NCR's Atleos. Highlights: Brink's acquires NCR Atleos for $6.6 billion.The deal...